Search

everythinglearnresearchcommunity

for

Search:↓

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Epidermal growth factor helps hair recover after chemotherapy.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

A rare genetic mutation causes severe immune issues, hair loss, and nail problems.

Mutations in Far2 mice cause hair loss due to sebaceous gland issues.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

An Australian with rare hair loss and eye conditions had a gene linked to both, not seen together before.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

"20-nail dystrophy" can have multiple causes.

Thymoma may link myasthenia gravis, nail dystrophy, and alopecia areata.

A child with rough nails also had hair loss and allergies.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Treatment improved some symptoms but not all.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Targeting specific T cells may help treat alopecia areata.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Cyproterone acetate effectively treats female hair loss by increasing healthy hair and decreasing unhealthy hair, but doesn't change hair thickness.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Sam Shuster identified three types of hair loss in psoriasis and emphasized the need for better research to understand them.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Scalp biopsy and digital phototrichogram help diagnose and manage different types of diffuse hair loss.

Spironolactone may help reduce hair loss in androgenic alopecia.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.